Immucell logo

Immucell

ICCC • NASDAQ • Stock Fundamentals

Immucell is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO F. Olivier Te Boekhorst, with a market cap of $95.0M.

Market Cap$95.0M
Employees80.0
CEOF. Olivier Te Boekhorst
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 14, 2026 · 14 days agoQ1 2026
View report
Next EarningsAug 13, 2026 · in 2 monthsAfter Market Close · Q2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Immucell logo

Immucell FAQ

Common questions about Immucell

Immucell (ICCC) has a market capitalization of $95.0M and trades on NASDAQ.

Immucell has approximately 80 employees.